SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-012072
Filing Date
2024-03-29
Accepted
2024-03-29 21:29:10
Documents
3
Period of Report
2024-03-25

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3909
2 ex24.htm EX-24 1036
3 ex24_001.jpg GRAPHIC 296504
  Complete submission text file 0001493152-24-012072.txt   415145
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Issuer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ANTIGENICS INC. 162 FIFTH AVENUE, SUITE 900 NEW YORK NY 10010
Business Address
Corvese Brian (Reporting) CIK: 0001393207 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12555 | Film No.: 24805274